| 1.2 |
3.6 |
GO:1903961 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) positive regulation of anion transmembrane transport(GO:1903961) |
| 0.7 |
2.2 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) chromosome movement towards spindle pole(GO:0051305) |
| 0.7 |
2.7 |
GO:0033986 |
response to methanol(GO:0033986) response to chromate(GO:0046687) |
| 0.6 |
3.0 |
GO:0003093 |
regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
| 0.6 |
3.0 |
GO:0003070 |
age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) |
| 0.6 |
2.4 |
GO:0072180 |
mesonephric duct morphogenesis(GO:0072180) |
| 0.6 |
2.2 |
GO:0032291 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.5 |
1.6 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.5 |
1.6 |
GO:2000910 |
regulation of cholesterol import(GO:0060620) negative regulation of cholesterol import(GO:0060621) regulation of sterol import(GO:2000909) negative regulation of sterol import(GO:2000910) |
| 0.5 |
2.0 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.5 |
2.0 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.4 |
1.2 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.4 |
1.2 |
GO:0010586 |
miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
| 0.4 |
1.5 |
GO:0051712 |
positive regulation of killing of cells of other organism(GO:0051712) |
| 0.4 |
2.9 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.3 |
1.0 |
GO:0003176 |
aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) notochord formation(GO:0014028) |
| 0.3 |
1.0 |
GO:0009648 |
photoperiodism(GO:0009648) |
| 0.3 |
3.0 |
GO:0030277 |
epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.3 |
3.3 |
GO:0046643 |
regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
| 0.3 |
0.7 |
GO:0048143 |
astrocyte activation(GO:0048143) |
| 0.3 |
0.6 |
GO:0007206 |
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.3 |
1.2 |
GO:0002478 |
antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
| 0.3 |
1.1 |
GO:0010727 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
| 0.3 |
0.8 |
GO:0019521 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.3 |
1.1 |
GO:0033622 |
integrin activation(GO:0033622) regulation of integrin activation(GO:0033623) positive regulation of integrin activation(GO:0033625) |
| 0.3 |
0.3 |
GO:0071166 |
ribonucleoprotein complex localization(GO:0071166) ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.3 |
1.3 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.3 |
0.8 |
GO:0061298 |
progesterone secretion(GO:0042701) retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.3 |
0.8 |
GO:0003289 |
septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
| 0.2 |
1.9 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.2 |
2.1 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.2 |
0.7 |
GO:0009992 |
cellular water homeostasis(GO:0009992) |
| 0.2 |
0.4 |
GO:0046532 |
regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.2 |
0.9 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.2 |
1.3 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.2 |
0.4 |
GO:0001704 |
formation of primary germ layer(GO:0001704) |
| 0.2 |
0.9 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.2 |
0.6 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.2 |
0.6 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.2 |
0.4 |
GO:0016046 |
detection of fungus(GO:0016046) |
| 0.2 |
1.5 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.2 |
0.4 |
GO:0014874 |
response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
| 0.2 |
5.3 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.2 |
1.7 |
GO:0006546 |
glycine catabolic process(GO:0006546) |
| 0.2 |
0.7 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.2 |
1.1 |
GO:1901503 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.2 |
0.9 |
GO:0032736 |
positive regulation of interleukin-13 production(GO:0032736) |
| 0.2 |
0.6 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.2 |
0.7 |
GO:0071436 |
sodium ion export(GO:0071436) |
| 0.2 |
0.5 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.2 |
0.4 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.2 |
0.5 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.2 |
2.3 |
GO:0031498 |
nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
| 0.2 |
0.8 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.2 |
1.1 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.2 |
0.3 |
GO:0032632 |
interleukin-3 production(GO:0032632) |
| 0.2 |
0.5 |
GO:0006273 |
lagging strand elongation(GO:0006273) |
| 0.2 |
0.2 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.2 |
1.3 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.2 |
0.8 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.2 |
1.0 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.2 |
0.2 |
GO:0070849 |
response to epidermal growth factor(GO:0070849) |
| 0.1 |
1.3 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 |
1.3 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.1 |
0.6 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
0.4 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.1 |
1.0 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.1 |
0.7 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 |
0.7 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.1 |
0.6 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.1 |
0.8 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.1 |
0.6 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 0.1 |
0.6 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 |
0.4 |
GO:0002677 |
negative regulation of chronic inflammatory response(GO:0002677) |
| 0.1 |
0.7 |
GO:0043306 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 |
0.2 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
| 0.1 |
0.1 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 |
0.7 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.4 |
GO:0034625 |
fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.2 |
GO:1902600 |
hydrogen ion transmembrane transport(GO:1902600) |
| 0.1 |
0.1 |
GO:0046984 |
regulation of hemoglobin biosynthetic process(GO:0046984) |
| 0.1 |
0.6 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.1 |
0.5 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 |
0.7 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.1 |
2.7 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
0.3 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.1 |
0.3 |
GO:1904036 |
negative regulation of epithelial cell apoptotic process(GO:1904036) regulation of establishment of cell polarity(GO:2000114) negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 0.1 |
0.5 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.1 |
0.7 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.1 |
0.3 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.1 |
0.4 |
GO:0019348 |
polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
| 0.1 |
0.8 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.1 |
1.9 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.1 |
0.3 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.5 |
GO:0051852 |
disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 0.1 |
0.3 |
GO:0048752 |
semicircular canal morphogenesis(GO:0048752) |
| 0.1 |
0.3 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.1 |
0.4 |
GO:0034204 |
lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.1 |
1.5 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.1 |
0.6 |
GO:2000189 |
regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
0.7 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.1 |
1.1 |
GO:0000050 |
urea cycle(GO:0000050) arginine catabolic process(GO:0006527) |
| 0.1 |
0.3 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.1 |
0.3 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
| 0.1 |
0.8 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.1 |
2.6 |
GO:0030593 |
neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
| 0.1 |
0.5 |
GO:0043045 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.1 |
3.0 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.1 |
0.4 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.6 |
GO:0015755 |
fructose transport(GO:0015755) |
| 0.1 |
0.5 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) proline catabolic process(GO:0006562) |
| 0.1 |
2.2 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.1 |
0.4 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.1 |
1.3 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.1 |
0.9 |
GO:0071451 |
removal of superoxide radicals(GO:0019430) cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
| 0.1 |
0.3 |
GO:0071679 |
cell proliferation in midbrain(GO:0033278) commissural neuron axon guidance(GO:0071679) |
| 0.1 |
1.4 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.1 |
0.5 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 |
0.3 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.1 |
0.9 |
GO:0032876 |
regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
| 0.1 |
0.3 |
GO:0009103 |
lipopolysaccharide biosynthetic process(GO:0009103) |
| 0.1 |
0.6 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.1 |
0.3 |
GO:0090267 |
positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.1 |
0.6 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
0.2 |
GO:0043550 |
regulation of lipid kinase activity(GO:0043550) |
| 0.1 |
1.3 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.1 |
0.8 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.2 |
GO:0070482 |
response to hypoxia(GO:0001666) response to decreased oxygen levels(GO:0036293) response to oxygen levels(GO:0070482) |
| 0.1 |
0.3 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
| 0.1 |
0.4 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
0.2 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.1 |
0.5 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 |
2.1 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.1 |
0.8 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.6 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.1 |
0.8 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
0.2 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.1 |
0.3 |
GO:0006922 |
obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
| 0.1 |
0.8 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.1 |
0.8 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 |
0.5 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.1 |
1.8 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.1 |
2.1 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.1 |
0.4 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.1 |
0.7 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.3 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.1 |
0.3 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
0.9 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
1.2 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.1 |
0.5 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.1 |
0.1 |
GO:0007059 |
chromosome segregation(GO:0007059) |
| 0.1 |
0.6 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.1 |
0.1 |
GO:0034014 |
response to triglyceride(GO:0034014) |
| 0.1 |
0.5 |
GO:0040001 |
establishment of mitotic spindle localization(GO:0040001) |
| 0.1 |
0.4 |
GO:0042416 |
dopamine biosynthetic process(GO:0042416) |
| 0.1 |
0.4 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.1 |
3.1 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.1 |
0.4 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.1 |
0.2 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.1 |
0.5 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 |
1.2 |
GO:0009086 |
methionine biosynthetic process(GO:0009086) |
| 0.1 |
1.3 |
GO:0050732 |
negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
| 0.1 |
0.4 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.1 |
0.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.9 |
GO:0007062 |
sister chromatid cohesion(GO:0007062) |
| 0.1 |
1.0 |
GO:0007004 |
telomere maintenance via telomerase(GO:0007004) |
| 0.1 |
0.3 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
0.9 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.1 |
1.8 |
GO:0051899 |
membrane depolarization(GO:0051899) |
| 0.1 |
0.9 |
GO:0042438 |
melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.1 |
0.7 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.1 |
0.3 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.1 |
0.1 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.1 |
0.2 |
GO:0010716 |
regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 |
0.5 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.1 |
0.4 |
GO:0071243 |
response to fungicide(GO:0060992) cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 |
0.3 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.1 |
0.5 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.1 |
0.3 |
GO:0032959 |
inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.1 |
0.7 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.1 |
2.6 |
GO:0042113 |
B cell activation(GO:0042113) |
| 0.1 |
0.6 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.1 |
0.2 |
GO:0046851 |
negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
| 0.1 |
0.1 |
GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity(GO:0043551) positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.1 |
0.5 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 |
0.1 |
GO:0051971 |
positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.1 |
0.8 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.1 |
0.6 |
GO:0040023 |
establishment of nucleus localization(GO:0040023) nucleus localization(GO:0051647) |
| 0.1 |
0.2 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.0 |
0.5 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 |
0.3 |
GO:0033522 |
histone H2A ubiquitination(GO:0033522) |
| 0.0 |
0.1 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.0 |
0.2 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.0 |
1.7 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.5 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.0 |
0.3 |
GO:0010896 |
regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.0 |
0.4 |
GO:0043174 |
pyrimidine-containing compound salvage(GO:0008655) cellular metabolic compound salvage(GO:0043094) pyrimidine nucleoside salvage(GO:0043097) nucleoside salvage(GO:0043174) |
| 0.0 |
0.2 |
GO:0070265 |
necrotic cell death(GO:0070265) |
| 0.0 |
0.2 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.0 |
0.5 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.0 |
0.2 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) actin filament reorganization(GO:0090527) |
| 0.0 |
0.2 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 |
1.0 |
GO:0031055 |
DNA replication-independent nucleosome assembly(GO:0006336) chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) DNA replication-independent nucleosome organization(GO:0034724) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 |
1.2 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.0 |
0.4 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.0 |
1.4 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.1 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.0 |
0.2 |
GO:0050665 |
hydrogen peroxide biosynthetic process(GO:0050665) |
| 0.0 |
0.2 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 0.0 |
0.4 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.3 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.0 |
0.1 |
GO:0006007 |
glucose catabolic process(GO:0006007) |
| 0.0 |
2.4 |
GO:0042742 |
defense response to bacterium(GO:0042742) |
| 0.0 |
0.8 |
GO:0035338 |
long-chain fatty-acyl-CoA metabolic process(GO:0035336) long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.0 |
0.3 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 |
0.5 |
GO:0032720 |
negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
| 0.0 |
1.3 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.0 |
0.6 |
GO:0006400 |
tRNA modification(GO:0006400) |
| 0.0 |
0.2 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
| 0.0 |
0.4 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.4 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.0 |
0.3 |
GO:0035246 |
peptidyl-arginine N-methylation(GO:0035246) |
| 0.0 |
0.2 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.0 |
0.4 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.0 |
0.1 |
GO:0014887 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 |
0.2 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.0 |
2.5 |
GO:0009636 |
response to toxic substance(GO:0009636) |
| 0.0 |
0.1 |
GO:0007090 |
obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
| 0.0 |
0.8 |
GO:0006691 |
leukotriene metabolic process(GO:0006691) |
| 0.0 |
0.1 |
GO:0009266 |
response to temperature stimulus(GO:0009266) |
| 0.0 |
0.4 |
GO:0006342 |
chromatin silencing(GO:0006342) |
| 0.0 |
0.7 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.0 |
0.1 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.0 |
0.1 |
GO:0035929 |
steroid hormone secretion(GO:0035929) |
| 0.0 |
0.1 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.0 |
0.7 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.1 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) cytoplasmic translation(GO:0002181) cytoplasmic translational initiation(GO:0002183) |
| 0.0 |
0.2 |
GO:0035444 |
nickel cation transport(GO:0015675) vanadium ion transport(GO:0015676) ferrous iron transport(GO:0015684) lead ion transport(GO:0015692) nickel cation transmembrane transport(GO:0035444) ferrous iron import(GO:0070627) iron ion import(GO:0097286) |
| 0.0 |
0.2 |
GO:0007128 |
meiotic prophase I(GO:0007128) meiosis I cell cycle phase(GO:0098764) |
| 0.0 |
0.1 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.0 |
0.2 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.0 |
0.8 |
GO:0051092 |
positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.0 |
0.2 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.0 |
0.5 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
0.4 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
0.5 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 |
0.4 |
GO:0045954 |
positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
| 0.0 |
0.5 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.0 |
0.7 |
GO:0008211 |
glucocorticoid metabolic process(GO:0008211) |
| 0.0 |
0.1 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.0 |
0.3 |
GO:0032259 |
methylation(GO:0032259) |
| 0.0 |
0.3 |
GO:0023058 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
| 0.0 |
4.4 |
GO:0008643 |
carbohydrate transport(GO:0008643) |
| 0.0 |
0.1 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.0 |
0.1 |
GO:0014831 |
intestine smooth muscle contraction(GO:0014827) gastro-intestinal system smooth muscle contraction(GO:0014831) |
| 0.0 |
1.0 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.2 |
GO:0060122 |
auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) inner ear receptor stereocilium organization(GO:0060122) |
| 0.0 |
0.5 |
GO:0046464 |
neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
| 0.0 |
0.2 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.0 |
0.2 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) negative regulation of stress fiber assembly(GO:0051497) |
| 0.0 |
0.3 |
GO:1902001 |
fatty acid transmembrane transport(GO:1902001) |
| 0.0 |
0.1 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 |
0.1 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.0 |
0.9 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.8 |
GO:0071804 |
cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.0 |
0.1 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.0 |
1.2 |
GO:0007422 |
peripheral nervous system development(GO:0007422) |
| 0.0 |
1.2 |
GO:0060041 |
retina development in camera-type eye(GO:0060041) |
| 0.0 |
0.4 |
GO:0006954 |
inflammatory response(GO:0006954) |
| 0.0 |
1.7 |
GO:0051592 |
response to calcium ion(GO:0051592) |
| 0.0 |
0.0 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 |
0.1 |
GO:0031635 |
adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) opioid receptor signaling pathway(GO:0038003) |
| 0.0 |
0.1 |
GO:1901798 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.0 |
1.5 |
GO:0000910 |
cytokinesis(GO:0000910) |
| 0.0 |
0.5 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 |
0.5 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.8 |
GO:0007051 |
spindle organization(GO:0007051) |
| 0.0 |
0.1 |
GO:0018101 |
citrulline metabolic process(GO:0000052) protein citrullination(GO:0018101) citrulline biosynthetic process(GO:0019240) |
| 0.0 |
3.2 |
GO:0006813 |
potassium ion transport(GO:0006813) |
| 0.0 |
0.2 |
GO:0042098 |
T cell proliferation(GO:0042098) |
| 0.0 |
0.3 |
GO:0030317 |
sperm motility(GO:0030317) |
| 0.0 |
0.4 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.0 |
1.1 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.0 |
0.2 |
GO:0048839 |
inner ear development(GO:0048839) |
| 0.0 |
2.9 |
GO:0048511 |
rhythmic process(GO:0048511) |
| 0.0 |
0.2 |
GO:1902582 |
single-organism intracellular transport(GO:1902582) |
| 0.0 |
1.2 |
GO:0007162 |
negative regulation of cell adhesion(GO:0007162) |
| 0.0 |
0.1 |
GO:0060423 |
foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) iris morphogenesis(GO:0061072) |
| 0.0 |
0.1 |
GO:0055009 |
atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.0 |
0.4 |
GO:0030325 |
adrenal gland development(GO:0030325) |
| 0.0 |
0.3 |
GO:0017015 |
regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
| 0.0 |
0.1 |
GO:0046718 |
viral entry into host cell(GO:0046718) |
| 0.0 |
0.3 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 |
0.2 |
GO:0048536 |
spleen development(GO:0048536) |
| 0.0 |
0.7 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.0 |
0.2 |
GO:0060334 |
regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 |
0.5 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
| 0.0 |
0.8 |
GO:0019079 |
viral genome replication(GO:0019079) |
| 0.0 |
0.2 |
GO:0060711 |
labyrinthine layer development(GO:0060711) |
| 0.0 |
0.9 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.0 |
1.3 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.0 |
0.4 |
GO:0072659 |
protein localization to plasma membrane(GO:0072659) protein localization to cell periphery(GO:1990778) |
| 0.0 |
0.4 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
| 0.0 |
0.5 |
GO:0019221 |
cytokine-mediated signaling pathway(GO:0019221) |
| 0.0 |
0.2 |
GO:0097696 |
JAK-STAT cascade(GO:0007259) STAT cascade(GO:0097696) |
| 0.0 |
1.1 |
GO:0019882 |
antigen processing and presentation(GO:0019882) |
| 0.0 |
2.0 |
GO:0008654 |
phospholipid biosynthetic process(GO:0008654) |
| 0.0 |
0.3 |
GO:0007188 |
adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
| 0.0 |
0.3 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.0 |
0.5 |
GO:0051318 |
G1 phase(GO:0051318) |
| 0.0 |
1.4 |
GO:0031295 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.0 |
0.6 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.0 |
0.2 |
GO:0030299 |
intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.0 |
0.0 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.0 |
1.1 |
GO:0016055 |
Wnt signaling pathway(GO:0016055) cell-cell signaling by wnt(GO:0198738) cell surface receptor signaling pathway involved in cell-cell signaling(GO:1905114) |
| 0.0 |
0.5 |
GO:0046847 |
filopodium assembly(GO:0046847) |
| 0.0 |
0.5 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.0 |
0.2 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.0 |
1.2 |
GO:0046777 |
protein autophosphorylation(GO:0046777) |
| 0.0 |
0.5 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.0 |
0.1 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.7 |
GO:0031668 |
cellular response to extracellular stimulus(GO:0031668) |
| 0.0 |
1.4 |
GO:0007586 |
digestion(GO:0007586) |
| 0.0 |
0.3 |
GO:0050772 |
positive regulation of cell morphogenesis involved in differentiation(GO:0010770) positive regulation of axonogenesis(GO:0050772) |
| 0.0 |
0.4 |
GO:0006490 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.0 |
5.0 |
GO:0050776 |
regulation of immune response(GO:0050776) |
| 0.0 |
0.7 |
GO:0050821 |
protein stabilization(GO:0050821) |
| 0.0 |
1.0 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.0 |
0.2 |
GO:0009994 |
oocyte differentiation(GO:0009994) oocyte development(GO:0048599) |
| 0.0 |
0.9 |
GO:0008543 |
fibroblast growth factor receptor signaling pathway(GO:0008543) cellular response to fibroblast growth factor stimulus(GO:0044344) response to fibroblast growth factor(GO:0071774) |
| 0.0 |
1.6 |
GO:0006401 |
RNA catabolic process(GO:0006401) |
| 0.0 |
0.2 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.0 |
0.4 |
GO:0019233 |
sensory perception of pain(GO:0019233) |
| 0.0 |
0.1 |
GO:0051259 |
protein oligomerization(GO:0051259) |
| 0.0 |
0.2 |
GO:0050906 |
detection of stimulus involved in sensory perception(GO:0050906) |
| 0.0 |
0.1 |
GO:0035587 |
purinergic receptor signaling pathway(GO:0035587) purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.0 |
0.2 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.0 |
GO:0060346 |
bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
| 0.0 |
0.2 |
GO:0000090 |
mitotic anaphase(GO:0000090) anaphase(GO:0051322) |
| 0.0 |
0.1 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.0 |
0.4 |
GO:0006885 |
regulation of pH(GO:0006885) |
| 0.0 |
0.1 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.0 |
0.7 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.0 |
0.1 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
0.1 |
GO:0006349 |
regulation of gene expression by genetic imprinting(GO:0006349) genetic imprinting(GO:0071514) |
| 0.0 |
0.1 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.0 |
0.3 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.0 |
0.0 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.0 |
0.2 |
GO:0002697 |
regulation of immune effector process(GO:0002697) |
| 0.0 |
0.0 |
GO:0050942 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
| 0.0 |
0.1 |
GO:0045749 |
obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
| 0.0 |
0.2 |
GO:0051591 |
response to cAMP(GO:0051591) |
| 0.0 |
0.1 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.0 |
0.1 |
GO:0051149 |
positive regulation of muscle cell differentiation(GO:0051149) |
| 0.0 |
0.3 |
GO:1900047 |
negative regulation of blood coagulation(GO:0030195) negative regulation of wound healing(GO:0061045) negative regulation of hemostasis(GO:1900047) |
| 0.0 |
0.5 |
GO:0051084 |
'de novo' posttranslational protein folding(GO:0051084) |
| 0.0 |
0.0 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.0 |
1.0 |
GO:0008203 |
cholesterol metabolic process(GO:0008203) |
| 0.0 |
0.4 |
GO:0071357 |
response to type I interferon(GO:0034340) type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
